Synergetics USA, Inc. (SURG) Reports Mixed Q3 Results: Beats on Bottom Line, Misses on Sales
Synergetics USA, Inc. (NASDAQ: SURG) reported Q3 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $14.7 million versus the consensus estimate of $14.91 million.